Clinical features | Values (number (%)) |
---|---|
Age(yr) | 51.3 ± 7.4 |
Gender | |
Male | 20 (76.92%) |
Female | 6 (23.08%) |
Aetiology | |
Hbs-Ag positive | 23 (88.46%) |
HCV-Ab positive | 3 (11.54%) |
Child-Pugh score | |
Class A | 26 (100%) |
Class B | 0 (0%) |
Tumour size | |
< 3 cm | 19 (73.07%) |
3-5 cm | 7 (26.93%) |
Tumour number | |
Single | 16 (61.53%) |
2–3 | 11 (38.47%) |
BCLC staging | |
Stage A | 18 (69.23%) |
Stage B | 8 (30.77%) |
Tumour differentiation | |
well | 9 (34.61%) |
moderate | 10 (38.46%) |
poorly | 7 (26.92%) |
AFP | 545 ± 892 |